UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$278M |
| 2 |
United Rentals
URI
|
+$213M |
| 3 |
Affiliated Managers Group
AMG
|
+$189M |
| 4 |
Yelp
YELP
|
+$146M |
| 5 |
Microsoft
MSFT
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$223M |
| 2 |
RTX Corp
RTX
|
+$188M |
| 3 |
AGN
Allergan Inc
AGN
|
+$184M |
| 4 |
Crown Castle
CCI
|
+$171M |
| 5 |
Mastercard
MA
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.34% |
| 2 | Technology | 14.73% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THOR
801
DELISTED
THORATEC CORPORATION
THOR
| $11.2M | 0.01% |
344,711
+87,879
| +34% | +$2.56M |
|
802
Centene
CNC
$33.1B
| $11.2M | 0.01% |
430,164
-152,244
| -26% | -$3.55M |
|
|
SPN
803
DELISTED
Superior Energy Services, Inc.
SPN
| $11.1M | 0.01% |
55,263
+3,802
| +7% | +$890K |
|
804
Extra Space Storage
EXR
$31.7B
| $11M | 0.01% |
188,391
+9,066
| +5% | +$519K |
|
805
Acadia Healthcare
ACHC
$3B
| $11M | 0.01% |
179,895
+1,315
| +0.7% | +$76.5K |
|
|
CPHD
806
DELISTED
Cepheid Inc
CPHD
| $11M | 0.01% |
202,298
-2,000
| -1% | -$101K |
|
807
iShares Russell 3000 ETF
IWV
$20.2B
| $11M | 0.01% |
89,548
| – | – |
|
|
ETFC
808
DELISTED
E*Trade Financial Corporation
ETFC
| $10.9M | 0.01% |
450,426
-76,241
| -14% | -$1.71M |
|
809
CAE Inc. Common Shares
CAE
$8.62B
| $10.9M | 0.01% |
833,605
+64,610
| +8% | +$833K |
|
|
IDTI
810
DELISTED
Integrated Device Technology I
IDTI
| $10.8M | 0.01% |
551,275
-42,790
| -7% | -$736K |
|
811
Boise Cascade
BCC
$2.98B
| $10.7M | 0.01% |
287,883
-600
| -0.2% | -$20.7K |
|
812
United Natural Foods
UNFI
$2.91B
| $10.7M | 0.01% |
138,071
-1,784
| -1% | -$126K |
|
813
Cousins Properties
CUZ
$5.06B
| $10.6M | 0.01% |
328,709
+3,968
| +1% | +$135K |
|
|
CBI
814
DELISTED
Chicago Bridge & Iron Nv
CBI
| $10.5M | 0.01% |
250,979
+1,348
| +0.5% | +$66.4K |
|
815
CoreCivic
CXW
$3.09B
| $10.5M | 0.01% |
288,414
-23,600
| -8% | -$849K |
|
816
Charles River Laboratories
CRL
$12.6B
| $10.5M | 0.01% |
164,344
-2,000
| -1% | -$125K |
|
|
LDRH
817
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $10.4M | 0.01% |
317,918
+63,718
| +25% | +$2.09M |
|
818
Bloomin' Brands
BLMN
$1.01B
| $10.4M | 0.01% |
419,986
+391,200
| +1,359% | +$8.23M |
|
819
EnerSys
ENS
$6.92B
| $10.4M | 0.01% |
168,401
-2,500
| -1% | -$147K |
|
|
TEN
820
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $10.4M | 0.01% |
183,414
-9,343
| -5% | -$502K |
|
|
AWAY
821
DELISTED
HOMEAWAY INC COM
AWAY
| $10.3M | 0.01% |
346,685
+25,710
| +8% | +$811K |
|
822
Toyota
TM
$220B
| $10.3M | 0.01% |
82,271
+1,684
| +2% | +$202K |
|
823
iShares MSCI South Korea ETF
EWY
$24.6B
| $10.3M | 0.01% |
186,662
+11,195
| +6% | +$637K |
|
824
Alexandria Real Estate Equities
ARE
$8.73B
| $10.3M | 0.01% |
115,624
+6,864
| +6% | +$574K |
|
|
DNR
825
DELISTED
Denbury Resources, Inc.
DNR
| $10.2M | 0.01% |
1,253,779
-11,667
| -0.9% | -$121K |
|
Similar funds
UBS AM's Q4 2014 Portfolio in Review
As of Q4 2014, UBS AM held 2,689 positions worth $105B, up 4.2% from $101B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2014 filing shows 129 new, 1,370 increased, 628 reduced and 77 closed positions. Its largest new stake was Restaurant Brands International: 383,271 shares worth $15.1M. The largest sale was Biogen, an estimated $223M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q4 2014 buy was Restaurant Brands International: 383,271 shares worth $15.1M.
- UBS AM added most to Celgene Corp in Q4 2014, an estimated $278M increase.
- UBS AM's biggest Q4 2014 reduction was Biogen, cutting an estimated $223M.
- UBS AM fully exited KINDER MORGAN MANAGEMENT LLC in Q4 2014, selling an estimated $45.3M.
- UBS AM's ten largest holdings make up 14% of its $105B portfolio in Q4 2014.
- UBS AM opened 129 new positions and closed 77 in Q4 2014.
- UBS AM's portfolio value rose 4.2% quarter-over-quarter to $105B.
Based on UBS AM's 13F filing for Q4 2014, filed 2 Feb 2015.